Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben‐David, Todd R. Golub, Benjamin A. Siranosian et al.|Nature|2018Cited by 943
Discovering the anticancer potential of non-oncology drugs by systematic viability profilingSteven M. Corsello, Todd R. Golub, Rohith T. Nagari et al.|Nature Cancer|2020Cited by 880
Development of small-molecule probes that selectively kill cells induced to express mutant RASMichel Weïwer, Benito Muñoz, Joshua A. Bittker et al.|Bioorganic & Medicinal Chemistry Letters|2011Cited by 238
A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assayMark‐Anthony Bray, Anne E. Carpenter, Mathias J. Wawer et al.|GigaScience|2017Cited by 182
Niche-based screening identifies small-molecule inhibitors of leukemia stem cellsKimberly A. Hartwell, Todd R. Golub, Peter G. Miller et al.|Nature Chemical Biology|2013Cited by 110